Nephrx
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nephrx - overview
Established
1995
Location
Kalamazoo, MI, US
Primary Industry
Biotechnology
About
NephRx is a biotechnology company dedicated to the discovery and development of therapeutic products for the treatment of acute kidney failure/disease and diseases of the gastrointestinal tract including mucositis.
Current Investors
ARCH Development Partners, White Pines Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Nephrx - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.